Search results
Showing 16 to 30 of 63 results for neuropathic pain
This guideline covers diagnosing and managing myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome (ME/CFS) in children, young people and adults. It aims to improve awareness and understanding about ME/CFS and when to suspect it, so that people are diagnosed earlier. It includes recommendations on diagnosis, assessment and care planning, safeguarding, access to care and managing ME/CFS and its symptoms.
This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.
This guideline covers prescribing of cannabis-based medicinal products for people with intractable nausea and vomiting, chronic pain, spasticity and severe treatment-resistant epilepsy.
This guideline covers managing acute and chronic pancreatitis in children, young people and adults. It aims to improve quality of life by ensuring that people have the right treatment and follow-up, and get timely information and support after diagnosis.
Low back pain and sciatica in over 16s: assessment and management (NG59)
This guideline covers assessing and managing low back pain and sciatica in people aged 16 and over. It outlines physical, psychological, pharmacological and surgical treatments to help people manage their low back pain and sciatica in their daily life. The guideline aims to improve people’s quality of life by promoting the most effective forms of care for low back pain and sciatica.
Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain (MIB238)
NICE has developed a medtech innovation briefing (MIB) on Evoke Spinal Cord Stimulator for managing chronic neuropathic or ischaemic pain .
efficacious. Source guidance details Comes from guidance Neuropathic pain in adults: pharmacological management in non-specialist...
Does early intervention to treat neuropathic pain reduce the likelihood of chronic pain?
Question Does early intervention to treat neuropathic pain reduce the likelihood of chronic pain? Any explanatory notes(if...
support, that influence participation* and quality of life in people with neuropathic pain? Any explanatory notes(if applicable) * The...
and quality of life in neuropathic pain? Any explanatory notes(if applicable) Pharmacological agents for neuropathic pain...
symptoms that present in healthcare settings, or whether different neuropathic pain conditions with different aetiologies, respond...
How should the symptomatic treatment of neuropathic pain relate to its cause?
CG173/7 Question How should the symptomatic treatment of neuropathic pain relate to its cause? Any explanatory notes(if applicable)
applicable) Source guidance details Comes from guidance Neuropathic pain in adults: pharmacological management in non-specialist...
What is the clinical and cost effectiveness of lidocaine patches for localised peripheral pain?
peripheral pain? Any explanatory notes(if applicable) Source guidance details Comes from guidance Neuropathic pain in...
Is there a potential for dependence associated with pharmacological agents for neuropathic pain?
potential for dependence associated with pharmacological agents for neuropathic pain? Any explanatory notes(if applicable) There has...